<sup>188</sup>Re在肿瘤治疗中的应用

孙逊

¹⁸⁸Re在肿瘤治疗中的应用

孙逊

文章导航 > 国际放射医学核医学杂志 > 2003, 27 > 4: (151-153)

引用本文:

Citation:

¹⁸⁸Re在肿瘤治疗中的应用

孙逊

430022 武汉, 华中科技大学同济医学院附属协和医院核医学科

作者简介: 孙逊(1977-),女,硕士研究生,主要从事肿瘤核医学研究。;

中图分类号: R817.5

Application of ¹⁸⁸Re in tumor treatment

SUN Xun

Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan 430022, China
CLC number: R817.5

摘要: 概述了放射性核素¹⁸⁸Re在肿瘤的骨转移治疗、放射免疫治疗、受体介导靶向治疗、腔内治疗及介入治疗等方面的应用,并简单介绍了¹⁸⁸Re治疗肿瘤的机制及优势。
- ¹⁸⁸Re /
- 肿瘤 /
- 内照射治疗
Abstract: The use of radionuclide ¹⁸⁸Re for bone metastases treatment,tumors radioimmunotherapy,receptor-targeted radiotherapy,intracavitary radiotherapy and intervention therapy were reviewed.The mechanism and advantage of ¹⁸⁸Re for tumor treatment were simply introduced.
- Rhenium-188 /
- tumor /
- endoradiotherapy
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Knapp FF Jr. Rhenium-188 a generator-derived radioisotope for cancer therapy[J]. Cancer Biother Radiopharm,1998, 13(5): 337-349.
[2]	Hsieh BT, Hsieh JF, Tsai SC, et al. Comparison of various rhenium-188 labeled diphosphonates for the treatment of bone metastases[J]. Nucl Med Biol, 1999. 26(8): 973-976.
[3]	Palmedo H, Guhlke S, Bender H, et al. Dose escalation study with Rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases[J]. Eur J Nucl Med, 2000, 27(2): 123-130.
[4]	Liepe K, Franke WG, Kropp J, et al. Comparison of Rhenium 188, Rhenium 186 HEDP and Strontium 89 in palliation of painful bone metastases[J]. Nuklearmedizin, 2000, 39(6): 146-151.
[5]	Blower PJ, Kettle AG, O'Doherty MJ, et al. 99mTc(V)DMSA quantitatively predicts 188Re (V)DMSA distribution in patients with prostate cancer metastatic to bone[J]. Eur J Nucl Med, 2000, 27(9): 1405-1409.
[6]	Limouris GS, Pirmettis Ⅰ, Frantzis AP, et al. Re-188(Sn) labeled -HEDP and -(V)DMSA in the treatment of painful osseous and disseminated soft tissue metastases[J]. Eur J Nuel Med, 1999, 26(suppl): 1208.
[7]	Murray A, Simms MS, Scholfield DP, et al. Production and characterization of ¹⁸⁸Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer[J]. J Nucl Med, 2001, 42(5): 726-732.
[8]	Lou C, Chen ZN, Bian HJ, et al. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb ¹⁸⁸Re-HAb18[J]. World J Gastroenterol, 2002, 8(1): 69-73.
[9]	Gestin JF, Loussouarn A, Bardies M, et al. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and ¹⁸⁸Re-labeled bivalent hapten: biodistribution and dosimetry studies[J]. J Nucl Med, 2001, 42(1): 146-153.
[10]	Ferro-Flores G, Pimentel-Gonzalez G, Gonzalez-Zavala MAW, et al. Preparation, biodistribution, and dosimetry of ¹⁸⁸Re-labeled MoAb iorceal and its F (ab')2 fragments by avidin-biotin strategy[J]. Nucl Med Biol, 1999, 26(1): 57-62.
[11]	Bender H, Zamom PO, Rhodes BA, et al. Clinical aspects of local and regional tumor therapy with ¹⁸⁸Re-RC-160[J].Antieaneer Res, 1997, 17(3B): 1705-1712.
[12]	Zinn KR, Buchsbaum D J, Chaudhuri TR, et al. Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with ⁹⁹Tc^m or ¹⁸⁸Re[J]. J Nucl Med, 2000, 41(5): 887-895.
[13]	Smith CJ, Sieckman GL, Owen NK, et al. Radiochemical investigations of[¹⁸⁸Re(H₂O)(CO)₃-diaminopropionic acid-SSSbombesin(7-14)NH₂]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies[J]. Anticancer Res,2003, 23(1A): 63-70.
[14]	Junfeng Y, Ruping Z, Xinlan D, et al. Intmtumoral injection with [(188)Re]rhenium sulfide suspension for treatment of transplanted human liver carcinoma in nude mice[J]. Nucl Med Biol, 2000, 27(4): 347-352.

[1]	章斌 . ¹⁸⁸Re直接标记octreotide的方法学. 国际放射医学核医学杂志, 2002, 26(5): 220-222.
[2]	唐美芳 , 赵惠阳 . 核素⁸⁹Sr治疗肿瘤骨转移性骨痛. 国际放射医学核医学杂志, 1995, 19(4): 150-152.
[3]	苏新辉 , 王荣福 , 刘秀杰 . 核素内照射治疗在血管成型术后预防再狭窄的研究进展. 国际放射医学核医学杂志, 1999, 23(4): 164-166.
[4]	傅尚志 , 张楚毅 . 肝癌内照射临床及实验研究进展. 国际放射医学核医学杂志, 1996, 20(5): 202-205.
[5]	何晓娃 , 周荫保 . ¹⁵³Sm-EDTMP治疗骨痛及其毒性. 国际放射医学核医学杂志, 1995, 19(4): 148-150.
[6]	曹井旭 , 唐谨 . 靶性放射性核素治疗骨转移. 国际放射医学核医学杂志, 1995, 19(4): 153-156.
[7]	金稚奎 , 谭天秩 . 骨转移瘤的放射性核素治疗. 国际放射医学核医学杂志, 1995, 19(4): 145-148.
[8]	童冠圣 . 核素标记微球治疗肝癌的实验与临床研究. 国际放射医学核医学杂志, 2000, 24(3): 116-119.
[9]	刘光伟 , 龚守良 . siRNA与肿瘤放射治疗. 国际放射医学核医学杂志, 2004, 28(4): 169-172.
[10]	郭艳婷 , 张鹏飞 , 刘强 . Smac与肿瘤放射治疗. 国际放射医学核医学杂志, 2013, 37(5): 309-313. doi: 10.3760/cma.j.issn.1673-4114.2013.05.014